Therapeutic effect of osimertinib plus cranial radiotherapy compared to osimertinib alone in NSCLC patients with EGFR-activating mutations and brain metastases: a retrospective study | Radiation Oncology User montaukwhaler, in the non small cell lung cancer subreddit, 11 Dec 2021